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& INTRODUCTION
BOLD MRI contrast results from changes in the micro-
vascular ratio of oxyhemoglobin (oxyHb) to deoxyhemoglo-
bin (deoxyHb) (1). DeoxyHb is paramagnetic, which results
in a local bulk magnetic susceptibility effect and subsequent
MRI signal change in T(2)*-weighted functional MRI scans
(1). Although BOLD contrast has been studied extensively
in functional MRI studies of the brain, limited investigation
has been performed in other tissues.
Juvenile idiopathic arthritis (JIA) is the most common
rheumatic disorder of childhood (2), with the knee being the
most frequently affected joint (3). With the increasing
availability and use of disease-modifying and antirheumatic
biologic drugs for the treatment of JIA (4), the early
determination of joint abnormality has become extremely
important. Given the lack of clinical and laboratory tests
that enable the functional evaluation of perisynovial
oxygenation in JIA, the use of BOLD MRI to measure early
soft tissue physiological imbalances due to hypoxia is
appealing (5).
In inflammatory arthritis, the increased metabolic
demand of the inflamed synovium and the inadequate
delivery of oxygen caused by poor perfusion through the
inflamed synovium (5) result in hypoxia within the
inflamed joint in the acute stage of arthritis. Consequently,
the synovial blood flow increases to compensate for the
hypoxic status of the joint. In JIA, despite the local
hyperemia, the synovial capillaries develop an abnormal
oxygen transportation capability (5,6), which may result in
abnormal concentrations of oxyHb and deoxyHb at the
capillary level. To date, no single imaging assay or surrogate
marker has been demonstrated to adequately reflect the
spectrum of metabolic events involved in inflammatory
arthritis. We hypothesized that BOLD MRI would be able to
reflect the state of oxygenation in the microcirculation of
periarticular tissues in JIA children at 1.5 Tesla as
previously shown for other pathological states (7).
Previous studies of our group in rabbit models of
inflammatory arthritis demonstrated the feasibility (8),
criteria validity (9), interframework reliability for data
acquisition (10), combination of region-of-interest (ROI)-
related reading parameters that provide the highest accu-
racy for discrimination of the presence or absence of
arthritis in acute and subacute stages of the disease (11),
and responsiveness of the technique to short-term joint
temperature changes (12). However, no previous study has
demonstrated whether the BOLD MRI technique is able to
differentiate inflammatory from healthy perisynovial tissue
at 1.5 Tesla and determine interval soft tissue changes as a
result of intraarticular corticosteroid injections in the knees
of JIA patients. In the present paper, we describe the BOLD
MRI methodology and preliminary results on the feasibility
of using BOLD MRI at 1.5 Tesla to measure the responsive-
ness (sensitivity to change) of the interval of soft-tissue
changes in JIA patients with unilateral knee arthritis
following intraarticular injection of corticosteroids as a
proof of concept. We knew in advance the expected
effectiveness of the injection procedure, which reduces
synovial inflammation in JIA in approximately 76% of cases
at 6 weeks after the injection (13).
& MATERIALS AND METHODS
The study protocol was approved by the Research Ethics
Committee of our institution. All patients’ parents or the
patients themselves provided informed consent for partici-
pation of their children or themselves in the study. Seven
(males, 2; females, 5) JIA (subtypes: systemic, 1; polyarti-
cular, 2; oligoarticular, 4) patients with ages ranging
between 6 and 16 (median, 9) years at the time of the MRI
examination were recruited from the Department of
Rheumatology of our institution for the study based on
acceptance for participation within the pool of patients who
fulfilled the study inclusion criteria. Four (57%) patients had
activity in the left knee, and 3 (43%) had activity in the right
knee. The median (range) duration of disease prior to the
MRI scan in the evaluated patients was 36 (1–60) months.
All patients had clinical signs of unilateral knee arthritis and
a clinical indication for intraarticular corticosteroid injec-
tion. The involvement of only one of the knees in each study
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patient was confirmed by performing MRI on both knees
because MRI would be able to demonstrate asymptomatic
involvement of the contralateral knee. The patients were
imaged immediately prior to and 45 days after the
procedure. Patients with any previous history of arthritis
in the unaffected knee, with chronic pulmonary disease, or
who required sedation for performance of the MRI
examination were ineligible for the study.
Ten (males, 7; females, 3) healthy control children (median
age, 14 years; range, 10–18 years) were imaged at a single time
point using the same MRI protocol used for the JIA patients.
Imaging Acquisition
The imaging was performed on a GE LX 1.5T MR magnet
(General Electrics Healthcare, Milwaukee, WI, USA) with a
maximum gradient strength of 2.2 Gauss/cm using an
extremity coil. Both knees of the JIA patients and control
subjects were imaged. Each knee was scanned separately. A
sagittal gradient-echo localizer was used to localize the
suprapatellar recess of the knee. A multiecho axial T2
susceptibility-weighted sequence (slice thickness = 5 mm,
TE= 40 msec, TR= 2000 msec, bandwidth = 62.5 KHz,
NEX=1.0, and FOV=17 cm) was applied, with 30-second
periods of normoxia and 30-second periods of hyperoxia
(100% O2 through a face mask at the rate of 15 L/min using
a Laerdal bag with an oxygen reservoir and a one-way
valve). The scan time for this sequence for each knee joint
included 2 min of scan time under normoxia and 2 min
under hyperoxia. A T1-weighted two-dimensional spin-echo
sequence was used for anatomical localization of the BOLD
data (8 contiguous axial slices, 17-cm FOV, 4-mm thickness,
TE= 10 ms, TR= 500 ms, 2 NEX, 160 phase-encoding steps,
and a 256x192 matrix).
Imaging Analysis
Anatomic images were aligned with corresponding
functional images to enable the delineation of ROIs
involving the synovium of the knee. Statistical reactivity
maps were then constructed with Stimulate software
(University of Minnesota Medical School, Minneapolis,
MN). The maps interpolated the 64x64 functional images
to overlay them onto the anatomic images. The maps
provided information about the number of voxels with r-
values above a pre-established threshold [expressed as a
percentage of the suprathreshold voxels in the ROI (% of
activated voxels)] and about the t score, indicating the
difference between the on and off signal intensities that
represent the activated and baseline states (DR2*) divided
by the error of signal difference (on-off difference) for the
knees at each time point. Graphically, the hyperoxic
stimulus and normoxia were represented by squared peaks
(on-signal intensity) and baseline squared curves (off-signal
intensity), respectively. We used the 0.01 threshold with a
100% ceiling scale of 1, a positive activation algorithm, and a
Figure 1 - Axial BOLD MR images of arthritic (a, b) and contralateral (c, d) knees of a 7-year-old female JIA patient obtained prior to (a) and 6
weeks after (b) intraarticular corticosteroid injection. The thin green lines delineate the ROIs used to derive reactivity maps for the perisynovial
regions. Note the increasedpercentageof activated voxels representing increasednumerical values for BOLDMRImeasurements observed in the
arthritic knee prior to local treatment (a) and its interval decrease (b) following treatment. Axial BOLDMR images of one knee of a healthy 14-
year-old male volunteer (e) show synovial reactivity represented by activated voxels similar to those of the contralateral knee of the JIA patient.
BOLD MRI in JIA: Preliminary Experience
Doria A et al.
CLINICS 2013;68(5):721-724
722
small ROI (11) for this study. A single operator (N.C.) traced
freehand-drawn ROIs involving the immediate 0.5 cm from
the bone contour of the proximal tibia and distal femur,
which involved the perisynovial region.
Statistical Analysis
We used a two-sample Student t-test to compare the
baseline (pre-injection) % of activated voxels and on-off
differences of BOLD MRI measurements between arthritic
and contralateral non-affected knees in JIA patients and
between the contralateral knees of JIA patients and control
knees of healthy subjects.
BOLD MRI results were reported as the mean¡standard
error (SE).
The baseline and 6-week post-injection BOLD MRI
measurements in the arthritic and contralateral non-affected
JIA knees were compared with paired Student t-tests.
Differences with a two-tailed p-value of less than 0.05
were considered to be significant.
& RESULTS
All subjects in this study tolerated the BOLD MRI
procedure well. One of the JIA patients underwent the
baseline procedure but, for reasons unrelated to the study,
could not participate in the 6-week imaging assessment. We
report the baseline results for 7 JIA patients and 10 control
subjects and the 6-week follow-up results for 6 JIA patients.
The numerical values of the BOLD MRI measurements
obtained in arthritic knees at baseline (prior to corticosteroid
injection) were greater than the numerical values obtained
in the contralateral non-affected knees of the JIA patients
(Figure 1). This result was noted either using the % of
activated voxels [mean value for arthritic and contralateral
knees, 12.14 (SE, 2.11) and 9.61 (SE, 0.88), respectively] or
on-off differences [mean value for arthritic and contralateral
knees, 2.71 (SE, 0.47) and 2.28 (SE, 0.11), respectively].
Nevertheless, there were no significant differences between
the measurements of the arthritic and contralateral non-
affected knees in terms of the % of activated voxels (p= 0.20)
or on-off differences (p= 0.21).
Conversely, the numerical BOLDMRI values measured in
the contralateral non-affected knees of the JIA patients
matched those obtained in the control subjects. The mean %
of activated voxels in the contralateral non-affected knees of
JIA children at baseline was 9.61 (SE, 0.88), and the value
was 9.54 (SE, 1.97) in the control knees. With regard to on-
off differences, the mean value measured in the contral-
ateral non-affected knees of JIA patients at baseline was 2.28
(SE, 0.11), and the value was 2.43 (SE, 0.36) in the control
knees. No significant differences were noted between the
contralateral non-affected knees and control knees using
either the % of activated voxels (p= 0.97) or on-off
differences (p= 0.61).
Regarding the relation to the sensitivity to change of the
BOLD MRI between pre-injection and 6-week-post-injection
measurements in the JIA arthritic knees, the values decreased
over time, but the differences were not significant at the pre-
established alpha level [% of activated voxels: pre-injection,
mean, 13.05 (SE, 2.95); 6-week-post-injection, 8.02 (SE, 1.08),
p=0.16; on-off differences: pre-injection,mean, 2.79 (SE, 0.75);
6-week-post-injection, 2.25 (SE, 0.33), p=0.53].
The BOLD MRI measurements over time in the contral-
ateral non-affected knees of JIA patients presented smaller
numerical interval differences than those presented by the
arthritic knees, but the differences were not significant. The
mean % of activated voxels measured in the contralateral
non-affected knees of the JIA patients at baseline was 11.57
(SE, 2.30), and at 6 weeks, the value was 9.43 (SE, 1.74,
p= 0.08). The mean on-off difference value measured in the
contralateral knees at baseline was 2.66 (SE, 0.50), and at 6
weeks, the value measured was 2.53 (0.28, p= 0.76).
& DISCUSSION
The results of this study indicate that the BOLD MRI
values were higher in the knees with active inflammation
than in contralateral unaffected knees, and the interval pre-
and post-injection changes were greater in the arthritic
group than in the contralateral joint group (Figure 1). As
this was a pilot study in humans with a small sample size,
no significant results were obtained. Therefore, we were
unable to demonstrate the feasibility of the technique at 1.5
Tesla and suggest further investigation of BOLD MRI for
arthritis with higher field strength scanners.
Compared with conventional 1.5 Tesla MRI units, high-
field-strength MRI scanners operating at 3 Tesla offer the
advantage of a 3- to 4-fold higher signal-to-noise ratio (SNR)
(14), which is essential for imaging techniques, such as
BOLD MRI, that yield minimal changes (15) when con-
ducted using conventional 1.5-Tesla MRI scanners. At 1.5
Tesla, BOLD imaging results in signal changes on the order
of 1–2%, whereas at 3 T, the signal change increases to 3–5%
(14). Given the large variability of BOLD MRI measure-
ments, as shown in this pilot study, this technique is less
suitable for clinical use at 1.5 Tesla. Considering that both
the SNR and the magnitude of changes in the BOLD signal
can be increased with the use of MR magnets with increased
field strength (3 Tesla and higher), this technique merits
further investigation at higher MRI field strengths.
The chief limitation of this study is its small sample size,
which is related to its status as a pilot study. The sample size
was opportunistic. Furthermore, no age- or gender-matching
was possible within the limitations of the small sample size of
the study. Nevertheless, documentation of the preliminary
results of this study enables other groups to carefully
consider how to conduct similar clinical arthritis experiments
in the future. In addition, our study encourages the pursuit of
further investigation of hypoxia-related changes in arthritis
using BOLDMRI at 3 Tesla or higher field-strength magnets.
In such future studies, the power/sample-size estimates can
be calculated based on the preliminary data as well as SNR
calculations of BOLD MRI data.
Previous studies have demonstrated that the BOLD MRI
signal represents oxygen extraction, which relates to local
synovial hyperemia as a compensatory mechanism for
hypoxia (9). This technique can thus be complementary to
dynamic contrast-enhanced MRI, which can also provide
information on synovial vascular permeability and tissue
perfusion (16). However, BOLD MRI has the advantage of
not requiring intravenous contrast injection.
If future clinical trials in larger samples of JIA patients
at 3 Tesla MRI demonstrate the value of BOLD MRI for
assessing hypoxic conditions in JIA joints, this technique
may be a valuable tool to provide guidance and follow-
up for systemic therapies using biological and disease-
modifying agents.
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